Likewise, another modulated protein i.e., SRC has been reported to increase its expression in human breast cancer by 4–30 fold which was evidenced via both immunohistochemistry and immunoblotting (Verbeek et al., 1996); was also predicted to be modulated by diosgenin interaction (binding energy -7.4 kcal/mol). This evidence concerns the gene SRC and breast cancer.